PIN16 - BUDGET IMPACT ANALYSIS OF INTRODUCING A READY-TO-USE, FULLY-LIQUID, PAEDIATRIC, HEXAVALENT VACCINE FOR CHILDHOOD IMMUNISATION IN THE UNITED KINGDOM
Abstract
Authors
D. Mathijssen J. Clark-Wright L.J. Wolfson X. Lu M. Heisen S. Klijn S. Carroll B. Alemayehu